A Decision Chart for Assessing and Improving the Transferability of Economic Evaluation Results Between Countries

By Robert Welte   Talitha Feenstra  

PharmacoEconomics, Vol. 22, Iss. 13, 2004-01 ,pp. : 857-876

Adis International

Access to resources Recommend Favorite

What Do International Pharmacoeconomic Guidelines Say about Economic Data Transferability?

By Barbieri Marco   Drummond Michael   Rutten Frans   Cook John   Glick Henry A.   Lis Joanna   Reed Shelby D.   Sculpher Mark   Severens Johan L.  

Value in Health, Vol. 13, Iss. 8, 2010-12 ,pp. : 1028-1037

Blackwell Publishing

Access to resources Recommend Favorite

Transferability of Model-Based Economic Evaluations: The Case of Trastuzumab for the Adjuvant Treatment of HER2-Positive Early Breast Cancer in the Netherlands

By Essers Brigitte A.B.   Seferina Shanley C.   Tjan-Heijnen Vivianne C.G.   Severens Johan L.   Novák Annoesjka   Pompen Marjolein   Oron Ulrich H.   Joore Manuela A.  

Value in Health, Vol. 13, Iss. 4, 2010-06 ,pp. : 375-380

Blackwell Publishing

Access to resources Recommend Favorite

Economic Evaluation of Nebivolol in the Treatment of Hypertension

By Maria Theresia Kaltwasser  

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 5, 2005-01 ,pp. : 319-324

Adis International

Access to resources Recommend Favorite

NICE guidance for economic evaluation updated

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 311, 2001-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite